Alzheimer's disease

Sage's phase 2 Alzheimer's drug shows signs of cognitive improvement—but there's a catch
Fierce Biotech
Fri, 04/1/22 - 10:47 am
SAGE Therapeutics
SAGE-718
Alzheimer's disease
clinical trials
Biogen Submits Final Plan for Confirmatory Aduhelm Trial
BioSpace
Thu, 03/31/22 - 10:14 am
Biogen
Aduhelm
clinical trials
Alzheimer's disease
Biogen, Eisai unveil new data on lecanemab, but questions linger on ARIA-E; Spatial biology outfit grabs $33M round
Endpoints
Tue, 03/22/22 - 11:19 pm
Eisai
Biogen
lecanemab
Alzheimer's disease
Scoop: Biogen will finally publish its PhIII results for Aduhelm
Endpoints
Wed, 03/16/22 - 10:22 am
Biogen
Aduhelm
Alzheimer's disease
Eisai hands off responsibility for Aduhelm to Biogen
Pharmaforum
Tue, 03/15/22 - 11:43 am
Eisai
Biogen
Aduhelm
Alzheimer's disease
Alzheimer's patient groups pressure U.S. to pay for Biogen drug
Reuters
Sun, 03/13/22 - 11:07 pm
Alzheimer's disease
Biogen
Aduhelm
patient groups
A trio of amyloid-targeted Alzheimer's drugs will soon see key results, but an analyst predicts only 50-50 odds for one
Endpoints
Wed, 03/9/22 - 11:09 pm
Alzheimer's disease
clinical trials
Roche
Eli Lilly
Biogen
donanemab
lecanemab
gantenerumab
Small biotech CEO exodus continues as vTv, a troubled former Alzheimer's player, sees chief leave after just 4 months
Endpoints
Fri, 03/4/22 - 10:09 am
biotech
vTv Therapeutics
Alzheimer's disease
Roche starts new four-year trial of Alzheimer’s drug gantenerumab
Pharmaforum
Fri, 03/4/22 - 09:48 am
Roche
Alzheimer's disease
clinical trials
gantenerumab
Biogen's Aduhelm still has blockbuster potential if everything breaks right: analyst
Fierce Pharma
Fri, 03/4/22 - 09:47 am
Biogen
Aduhelm
Alzheimer's disease
physicians
analysts
Biogen, struggling to sell Alzheimer's drug, begins layoffs to save money
BioPharma Dive
Thu, 03/3/22 - 12:12 pm
Biogen
layoffs
Aduhelm
Alzheimer's disease
Cassava 10K Filing Warns of Anticipated Hold, Paints Dire Picture of Alzheimer's Space
BioSpace
Thu, 03/3/22 - 10:23 am
Cassava Sciences
FDA
clinical trials
Alzheimer's disease
simufilam
AbbVie bets $130M on UCB spinout, bagging early-phase Alzheimer's and depression prospect
Fierce Biotech
Tue, 03/1/22 - 10:42 am
AbbVie
M&A
Neuroscience
Syndesi Therapeutics
UCB Pharma
Alzheimer's disease
depression
3 more deaths among patients on Biogen's Aduhelm fuel safety concerns, though no link established: analyst
Fierce Pharma
Wed, 02/16/22 - 11:19 pm
Biogen
Aduhelm
Alzheimer's disease
patient deaths
AC Immune's Janssen-partnered Alzheimer's vaccine spurs tau-attacking antibodies in early-stage trial
Fierce Biotech
Tue, 02/15/22 - 10:32 am
AC Immune
Janssen
JNJ
vaccines
Alzheimer's disease
clinical trials
Eli Lilly and Roche ask CMS not to be lumped in with Aduhelm’s restrictive judgment
Endpoints
Mon, 02/14/22 - 11:06 am
Eli Lilly
Roche
Biogen
Alzheimer's disease
Aduhelm
CMS
Denali Receives Formal Letter Regarding FDA Hold On Alzheimer's Potential Program
Benzinga
Mon, 02/14/22 - 11:00 am
Denali Therapeutics
FDA
DNL919
clinical hold
Alzheimer's disease
Cassava scores a win as FDA declines to intervene in petition to stop its Alzheimer's drug trials
Fierce Biotech
Fri, 02/11/22 - 11:41 am
Cassava Sciences
FDA
clinical trials
Alzheimer's disease
simufilam
Eisai bites back against restricted coverage plan for Aduhelm
Pharmaforum
Thu, 02/10/22 - 10:16 am
Eisai
Biogen
Aduhelm
Alzheimer's disease
FDA
CMS
Backing Biogen, 75+ House Republicans call on CMS to abandon its decision to limit amyloid-targeted Alzheimer's drugs to trials
Endpoints
Wed, 02/9/22 - 10:53 pm
Biogen
Aduhelm
CMS
Alzheimer's disease

Pages